Top Story

Vitamin D supplementation fails to lower BP

March 31, 2015

Vitamin D does not appear to be effective as a means of lowering BP, either in individual patients or as a population-level intervention, according to recent findings.

“In the 5 years since the first meta-analyses were published, a proliferation of randomized clinical trials has studied vitamin D and CV health,” the researchers wrote. “We therefore sought to update a systematic review of randomized clinical trials to evaluate whether vitamin D supplementation reduces BP when compared with placebo across a range of study populations and vitamin D analogues.”

Monika Sanghavi, MD In the Journals

Number of births may affect atherosclerosis risk in women

March 31, 2015
The number of live births is associated with subclinical coronary and aortic atherosclerosis in women, according to new data from the Dallas Heart Study.Researchers…
thumbnail for video 4143327648001 Meeting News CoverageVideo

Researcher looks at relationship between atopic dermatitis, obesity and cardiovascular disease

March 30, 2015
SAN FRANCISCO — In this video, Jonathan I. Silverberg, MD, PhD, MPH, discusses studies examining cardiovascular risk in atopic dermatitis that he reviewed at the…
FDA News

FDA: Use of TAVR system expanded to include aortic valve-in-valve replacement

March 30, 2015
The FDA has expanded the approved use of the CoreValve system to include aortic valve-in-valve replacement, according to an agency press release.The new approval expands…
4143177886001 th Meeting News CoverageVideo

VIDEO: Results from three trials suggest 'significant progress' for TAVR technology

March 30, 2015
SAN DIEGO — In this video, Steven R. Bailey, MD, chief of cardiology at the University of Texas Health Sciences Center and Cardiology Today's Intervention
More News Headlines »
Obesity Consults: Volume 2, Number 4 Obesity and the Cardiovascular System

Obesity Consults: Volume 2, Number 4
Obesity and the Cardiovascular System

This activity is supported by an educational grant from Eisai, Inc. and Vivus, Inc.

Obesity is associated with a wide range of comorbid conditions, including diabetes, hypertension, sleep apnea, and…
More »
Meeting News Coverage Video
4138851692001 th

VIDEO: EMBRACE-STEMI yields 'hypothesis-generating' results despite drug not meeting study endpoints

March 27, 2015
SAN DIEGO — In this video, C. Michael Gibson, MD, of Beth Israel Deaconess Medical Center, Harvard Medical…
More »
Obesity Consults: Volume 2, Number 2 Obesity Forum 2014 Highlights

Obesity Consults: Volume 2, Number 2
Obesity Forum 2014 Highlights

This activity is supported by educational grants from Takeda Pharmaceuticals International, Inc., US Region and Orexigen Therapeutics, Inc; Eisai, Inc.; Novo Nordisk; Vivus, Inc.

Management of obesity is complex, factoring in psychological, environmental, and physiologic causes. Treatment options…
More »